£1.6M
The funding round was led by DSW Ventures with backing from Mercia and SFC Capital.
Developer of a biodegradable biomaterial used for 3D printed medical implants.
Nottingham-based medical technology company that has developed a biodegradable biomaterial for 3D printed implants.
Cash at bank
Net assets
Shareholders' funds
Cash, assets and headcount from 4D Biomaterials's latest Companies House filing — with year-on-year movement, free with a Winfred account.

Phil Smith
CEO
Phil brings executive experience from leadership roles at 4D Biomaterials, 4D Medicine, and Interface Polymers. He previously worked in business development and materials sciences at the University of Warwick and Warwick Ventures.
The funding round was led by DSW Ventures with backing from Mercia and SFC Capital.